Abbott Laboratories Profile

<div class='circular--portrait' style='background:#8A0CCF;color: white;font-size:3em;padding-top: 35px;;'>ABT</div>

Performance

11 / 100

Odds of Distress

11
Analyze Filter   Earnings Report: April 15, 2020
Equity ratings for Abbott Laboratories are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 27, 2019 and ending today January 25, 2020. Click here to learn more.

Abbott Laboratories Profile

Next earnings report is expected on April 15, 2020. Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 103000 people. more on Abbott Laboratories
Abbott Laboratories Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Abbott Laboratories SEC Filings
Abbott Laboratories SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameAbbott Laboratories
ChairmanMiles WhiteView All
Thematic Classifications
Active investing themes Abbott Laboratories currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 4 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Abbott Laboratories
Piotroski F Score
Academic score to determine the current strength of Abbott Laboratories financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Abbott Laboratories ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: A-Very Good
Profitability
Few selected profitability drivers of Abbott Laboratories representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Abbott Laboratories (ABT) is traded on BATS Exchange in USA. It is located in 100 Abbott Park Road and employs 103,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 159.87 B. Abbott Laboratories runs under Healthcare sector within Medical Devices industry. The entity has 1.77 B outstanding shares of which 20.16 M shares are presently shorted by investors with about 5.01 days to cover shorted positions. ABBOTT LABORATORI has about 4.34 B in cash with 5.49 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45.
Check Abbott Laboratories Probability Of Bankruptcy

Ownership Allocation (%)

Abbott Laboratories Target Price Odds Analysis

Odds Below 91.86HorizonTargetOdds Above 91.86
99.87%30 days 91.86 0.12%
Based on normal probability distribution, the odds of Abbott Laboratories to move above current price in 30 days from now is near 1 (This Abbott Laboratories probability density function shows the probability of Abbott Laboratories Stock to fall within a particular range of prices over 30 days) .

Abbott Laboratories Top Holders

Abbott Laboratories Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Abbott Laboratories Against Markets

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Abbott Laboratories Upcoming and Recent Events

Abbott Laboratories Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportJanuary 22, 2020
Next Earnings ReportApril 15, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndJanuary 22, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Abbott Laboratories Corporate Filings

Abbott Laboratories SEC Reporting

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Other Events. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. Termination of a Material Definitive Agreement
Financial Statements and Exhibits. Other Events
Unclassified Corporate Event

Abbott Laboratories Distributions to stockholders

Abbott Laboratories Corporate Directors

Samuel Scott Independent Director
Nancy McKinstry Independent Director
James Farrell Independent Director
Please continue to Trending Equities. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Company logos by clearbit